pmc logo imageJournal ListSearchpmc logo image
Logo of vhriskmanJournal URL: redirect3.cgi?&&auth=0DOPsEsFaVsJp1HX-iGAWuIWxVDTwW8rOGrPdnQJf&reftype=publisher&issue-id=175367&journal-id=391&FROM=TOC|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://dovepress.com/articles.php?journal_id=69
Other Issues:  previous | next | latest | archive
Volume 3(2);  April 2007
Reviews
Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
Kirk A Bronander and Michael J Bloch
Vasc Health Risk Manag. 2007 April; 3(2): 181–190.
PMCID: PMC1994026
Sirolimus-eluting coronary stents: a review
Alexandre Abizaid
Vasc Health Risk Manag. 2007 April; 3(2): 191–201.
PMCID: PMC1994032
Review of sitagliptin phosphate: a novel treatment for type 2 diabetes
Baptist Gallwitz
Vasc Health Risk Manag. 2007 April; 3(2): 203–210.
PMCID: PMC1994027
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination
Andreas Pfützner, Birgit Wilhelm, and Thomas Forst
Vasc Health Risk Manag. 2007 April; 3(2): 211–220.
PMCID: PMC1994031
Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome
Caroline Schmidt-Lucke and Heinz-Peter Schultheiss
Vasc Health Risk Manag. 2007 April; 3(2): 221–228.
PMCID: PMC1994029
Epidemiology, classification, and modifiable risk factors of peripheral arterial disease
Nicolas W Shammas
Vasc Health Risk Manag. 2007 April; 3(2): 229–234.
PMCID: PMC1994028
Original Research
Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial
Przemyslaw Kardas
Vasc Health Risk Manag. 2007 April; 3(2): 235–242.
PMCID: PMC1994030
Other Issues:  previous | next | latest | archive